Arbutus Biopharma (ABUS) Non Operating Income (2015 - 2026)
Arbutus Biopharma (ABUS) reported Non Operating Income of $821,000 for Q2 2026, down 20.7% from $1.04 million a year earlier but up 4.3% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Non Operating Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arbutus Biopharma's Non Operating Income came in at $4.06 million, down 23.9% year-over-year; for FY2025, it was $4.66 million, down 27.2% from FY2024.
- By year, Non Operating Income came in at $6.4 million in FY2024 (+21.8%), $5.25 million in FY2023, $444,000 in FY2022 and -$2.73 million in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$750,000 in Q3 2021 and a high of $1.79 million in Q2 2024.
- Year over year, Non Operating Income gained in two of the last eight quarters, with an average decline of 17.2%.
- The high point for year-over-year Non Operating Income in five years was Q3 2023 (growth of 495.9%); the low point was Q3 2025 (a decline of 46.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $787,000 (Q1 2026), $1.53 million (Q4 2025) and $917,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Arbutus Biopharma | 926.90 Mn | 553.88 Mn | - | 821,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 821,000.00 |
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | -347,000.00 |
| Dec 31, 2021 | -525,000.00 |
| Sep 30, 2021 | -750,000.00 |
API Access
Arbutus Biopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();